{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:53:05Z","timestamp":1777715585444,"version":"3.51.4"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,4,1]],"date-time":"2003-04-01T00:00:00Z","timestamp":1049155200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2003,4]]},"DOI":"10.1007\/bf02988444","type":"journal-article","created":{"date-parts":[[2008,11,15]],"date-time":"2008-11-15T11:26:59Z","timestamp":1226748419000},"page":"79-89","source":"Crossref","is-referenced-by-count":166,"title":["PET studies in dementia"],"prefix":"10.1007","volume":"17","author":[{"given":"Karl","family":"Herholz","sequence":"first","affiliation":[]}],"member":"297","reference":[{"issue":"9","key":"BF02988444_CR1","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1212\/WNL.56.9.1133","volume":"56","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Stevens JC, Ganguli M, Tangalos EG, Cummings JL, Dekosky ST. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.Neurology 2001; 56 (9): 1133\u20131142.","journal-title":"Neurology"},{"key":"BF02988444_CR2","volume-title":"Neuroenergetics: Relevance for functional brain imaging","author":"RS Frackowiak","year":"2001","unstructured":"Frackowiak RS, Magistretti PJ, Shulman RG, Altman JS, Adams M. Neuroenergetics: Relevance for functional brain imaging. Strasbourg: Human Frontier Science Program; 2001."},{"issue":"1","key":"BF02988444_CR3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/jcbfm.1981.4","volume":"1","author":"L Sokoloff","year":"1981","unstructured":"Sokoloff L. Localization of functional activity in the central nervous system by measurement of glucose utilization with radioactive deoxyglucose. [Review]J Cereb Blood Flow Metab 1981; 1 (1): 7\u201336.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"BF02988444_CR4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1471-4159.1980.tb04643.x","volume":"34","author":"M Mata","year":"1980","unstructured":"Mata M, Fink DJ, Gainer H, Smith CB, Davidsen L, Savaki H, et al. Activity-dependent energy metabolism in rat posterior pituitary primarily reflects sodium pump activityJ Neurochem 1980; 34 (1): 213\u2013215.","journal-title":"J Neurochem"},{"issue":"1","key":"BF02988444_CR5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1073\/pnas.95.1.316","volume":"95","author":"NR Sibson","year":"1998","unstructured":"Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity.Proc Natl Acad Sci USA 1998; 95 (1): 316\u2013321.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"BF02988444_CR6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.33.8.961","volume":"33","author":"NL Foster","year":"1983","unstructured":"Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Alzheimer\u2019s disease: focal cortical changes shown by positron emission tomography.Neurology 1983; 33 (8): 961\u2013965.","journal-title":"Neurology"},{"issue":"1","key":"BF02988444_CR7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00002093-199505000-00004","volume":"9","author":"K Herholz","year":"1995","unstructured":"Herholz K. FDG PET and differential diagnosis of dementia.Alzheimer Disease & Associated Disorders 1995; 9 (1): 6\u201316.","journal-title":"Alzheimer Disease & Associated Disorders"},{"key":"BF02988444_CR8","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/nimg.2002.1208","volume":"17","author":"K Herholz","year":"2002","unstructured":"Herholz K, Salmon E, Perani D, Baron JC, Holthoff V, Fr\u00f6lich L, et al. Discrimination between Alzheimer Dementia and Controls by Automated Analysis of Multicenter FDG PET.Neuroimage 2002; 17: 302\u2013316.","journal-title":"Neuroimage"},{"key":"BF02988444_CR9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/hbm.10069","volume":"18","author":"G Zuendorf","year":"2003","unstructured":"Zuendorf G, Kerrouche N, Herholz K, Baron JC. An efficient principal component analysis for multivariate 3D voxelbased mapping of brain functional imaging data sets as applied to FDG-PET and normal aging.Hum Brain Mapp 2003; 18: 13\u201321.","journal-title":"Hum Brain Mapp"},{"issue":"1","key":"BF02988444_CR10","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease.Ann Neurol 1997; 42 (1): 85\u201394.","journal-title":"Ann Neurol"},{"issue":"10","key":"BF02988444_CR11","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/35094500","volume":"2","author":"DA Gusnard","year":"2001","unstructured":"Gusnard DA, Raichle ME, Raichle ME. Searching for a baseline: functional imaging and the resting human brain.Nat Rev Neurosci 2001; 2 (10): 685\u2013694.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"BF02988444_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1148\/radiology.198.3.8628880","volume":"198","author":"JH Burdette","year":"1996","unstructured":"Burdette JH, Minoshima S, Vander Borght T, Tran, DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections.Radiology 1996; 198 (3): 837\u2013843.","journal-title":"Radiology"},{"issue":"1","key":"BF02988444_CR13","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/nimg.1998.0381","volume":"9","author":"M Signorini","year":"1999","unstructured":"Signorini M, Paulesu E, Friston K, Perani D, Colleluori A, Lucignani G, et al. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: A clinical validation of statistical parametric mapping.Neuroimage 1999; 9 (1): 63\u201380.","journal-title":"Neuroimage"},{"issue":"4","key":"BF02988444_CR14","first-page":"548","volume":"42","author":"K Ishii","year":"2001","unstructured":"Ishii K, Willock F, Minoshima S, Drzezga A, Ficaro EP, Cross DJ, et al. Statistical brain mapping of18F-FDG PET in Alzheimer\u2019s disease: validation of anatomic standardization for atrophied brains.J Nucl Med 2001; 42 (4): 548\u2013557.","journal-title":"J Nucl Med"},{"issue":"1","key":"BF02988444_CR15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/(SICI)1097-0193(200005)10:1<39::AID-HBM50>3.0.CO;2-B","volume":"10","author":"E Salmon","year":"2000","unstructured":"Salmon E, Collette F, Degueldre C, Lemaire C, Franck G. Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer\u2019s disease.Hum Brain Mapp 2000; 10 (1): 39\u201348.","journal-title":"Hum Brain Mapp"},{"issue":"4","key":"BF02988444_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0197-4580(97)00056-0","volume":"18","author":"H Braak","year":"1997","unstructured":"Braak H, Braak E. Frequency of stages of Alzheimer-related lesions in different age categories.Neurobiol Aging 1997; 18 (4): 351\u2013357.","journal-title":"Neurobiol Aging"},{"issue":"12","key":"BF02988444_CR17","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment.Arch Neurol 2001; 58 (12): 1985\u20131992.","journal-title":"Arch Neurol"},{"key":"BF02988444_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein MF, Katzman R, Price, D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease.Neurology 1984; 34: 939\u2013944.","journal-title":"Neurology"},{"issue":"Suppl 3","key":"BF02988444_CR19","first-page":"24","volume":"5","author":"K Herholz","year":"1998","unstructured":"Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al. Metabolic impairment of association cortex predicts progression in Alzheimer\u2019s disease: a prospective multicenter positron emission tomography (PET) study.Eur J Neurol 1998; 5 (Suppl 3): S24.","journal-title":"Eur J Neurol"},{"issue":"4","key":"BF02988444_CR20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00001756-200103260-00045","volume":"12","author":"E Arnaiz","year":"2001","unstructured":"Arnaiz E, Jelic V, Almkvist O, Wahlund LO, Winblad B, Valind S, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment.Neuroreport 2001; 12 (4): 851\u2013855.","journal-title":"Neuroreport"},{"issue":"Suppl","key":"BF02988444_CR21","first-page":"426","volume":"21","author":"A Drzezga","year":"2001","unstructured":"Drzezga A, Lautenschlager N, Minoshima S, Spiegel S, Kurz A, Schwaiger M. Early identification of patients with Alzheimer\u2019s disease in a MCI group using F-18 FDG PET.J Cereb Blood Flow Metab 2001; 21 (Suppl): S426.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"6","key":"BF02988444_CR22","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","volume":"98","author":"EM Reiman","year":"2001","unstructured":"Reiman EM, Caselli RJ, Chen K, Alexander GE, Bandy D, Frost J. Declining brain activity in cognitively normal apolipoprotein E epsilon 4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer\u2019s disease.Proc Natl Acad Sci USA 2001; 98 (6): 3334\u20133339.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"BF02988444_CR23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, et al. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.N Engl J Med 1996; 334 (12): 752\u2013758.","journal-title":"N Engl J Med"},{"issue":"19","key":"BF02988444_CR24","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.191044198","volume":"98","author":"MJ Leon de","year":"2001","unstructured":"de Leon MJ, Convit A, Wolf OT, Tarshish CY, DeSanti S, Rusinek H, et al. Prediction of cognitive decline in normal elderly subjects with 2-F-18-fluoro-2-deoxy-d-glucose positron-emission tomography (FDGPET).Proc Natl Acad Sci USA 2001; 98 (19): 10966\u201310971.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"BF02988444_CR25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jnnp.62.6.596","volume":"62","author":"S Yamaguchi","year":"1997","unstructured":"Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer\u2019s disease as shown by MRI and PET.J Neurol Neurosurg Psychiatry 1997; 62 (6): 596\u2013600.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"BF02988444_CR26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1212\/WNL.59.3.364","volume":"59","author":"RS Wilson","year":"2002","unstructured":"Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons.Neurology 2002; 59 (3): 364\u2013370.","journal-title":"Neurology"},{"issue":"5","key":"BF02988444_CR27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1176\/ajp.156.5.675","volume":"156","author":"HS Mayberg","year":"1999","unstructured":"Mayberg HS, Liotti M, Brannan SK, McGinnis S, Mahurin RK, Jerabek PA, et al. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness.Am J Psychiatry 1999; 156 (5): 675\u2013682.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"BF02988444_CR28","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1212\/WNL.50.2.380","volume":"50","author":"N Hirono","year":"1998","unstructured":"Hirono N, Mori E, Ishii K, Ikejiri Y, Imamura T, Shimomura T, et al. Frontal lobe hypometabolism and depression in Alzheimer\u2019s disease.Neurology 1998; 50 (2): 380\u2013383.","journal-title":"Neurology"},{"issue":"6","key":"BF02988444_CR29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1159\/000017196","volume":"10","author":"K Herholz","year":"1999","unstructured":"Herholz K, Nordberg A, Salmon E, Perani D, Kessler J, Mielke R, et al. Impairment of neocortical metabolism predicts progression in Alzheimer\u2019s disease.Dement Geriatr Cogn Disord 1999; 10 (6): 494\u2013504.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"15","key":"BF02988444_CR30","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1073\/pnas.90.15.7019","volume":"90","author":"A Kumar","year":"1993","unstructured":"Kumar A, Newberg A, Alavi A, Berlin J, Smith R, Reivich M. Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study.Proc Natl Acad Sci USA 1993; 90 (15): 7019\u20137023.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"BF02988444_CR31","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","volume":"51","author":"D Neary","year":"1998","unstructured":"Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, Black S, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria.Neurology 1998; 51 (6): 1546\u20131554.","journal-title":"Neurology"},{"issue":"3","key":"BF02988444_CR32","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archneur.55.3.302","volume":"55","author":"A Kertesz","year":"1998","unstructured":"Kertesz A, Munoz D. Pick\u2019s disease, frontotemporal dementia, and Pick complex: emerging concepts.Arch Neurol 1998; 55 (3): 302\u2013304.","journal-title":"Arch Neurol"},{"issue":"5","key":"BF02988444_CR33","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1159\/000017251","volume":"11","author":"M Lindau","year":"2000","unstructured":"Lindau M, Almkvist O, Kushi J, Boone K, Johansson SE, Wahlund LO, et al. First symptoms\u2014frontotemporal dementia versus Alzheimer\u2019s disease.Dement Geriatr Cogn Disord 2000; 11 (5): 286\u2013293.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"BF02988444_CR34","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I","volume":"46","author":"JC Swieten van","year":"1999","unstructured":"van Swieten JC, Stevens M, Rosso SM, Rizzu P, Joosse M, de Koning I, et al. Phenotypic variation in hereditary frontotemporal dementia with tau mutations.Ann Neurol 1999; 46 (4): 617\u2013626.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"BF02988444_CR35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-510X(02)00102-8","volume":"199","author":"K Hosaka","year":"2002","unstructured":"Hosaka K, Ishii K, Sakamoto S, Mori T, Sasaki M, Hirono N, et al. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.J Neurol Sci 2002; 199 (1\u20132): 67\u201371.","journal-title":"J Neurol Sci"},{"issue":"1","key":"BF02988444_CR36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/00005072-199601000-00006","volume":"55","author":"MB Feany","year":"1996","unstructured":"Feany MB, Mattiace LA, Dickson DW. Neuropathologic overlap of progressive supranuclear palsy, Pick\u2019s disease and corticobasal degeneration.J Neuropathol Exp Neurol 1996; 55 (1): 53\u201367","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"BF02988444_CR37","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF00862982","volume":"239","author":"H Karbe","year":"1992","unstructured":"Karbe H, Grond M, Huber M, Herholz K, Kessler J, Heiss WD. Subcortical damage and cortical dysfunction in progressive supranuclear palsy demonstrated by positron emission tomography.J Neurol 1992; 239 (2): 98\u2013102.","journal-title":"J Neurol"},{"issue":"2","key":"BF02988444_CR38","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneur.58.2.300","volume":"58","author":"B Soong","year":"2001","unstructured":"Soong B, Liu R, Wu L, Lu Y, Lee H. Metabolic characterization of spinocerebellar ataxia type 6.Arch Neurol 2001; 58 (2): 300\u2013304.","journal-title":"Arch Neurol"},{"issue":"3","key":"BF02988444_CR39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/syn.890110303","volume":"11","author":"ND Volkow","year":"1992","unstructured":"Volkow ND, Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, et al. Long-term frontal brain metabolic changes in cocaine abusers.Synapse 1992; 11 (3): 184\u2013190.","journal-title":"Synapse"},{"issue":"23","key":"BF02988444_CR40","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJM199712043372306","volume":"337","author":"T Erkinjuntti","year":"1997","unstructured":"Erkinjuntti T, Ostbye T, Steenhuis R, Hachinski V. The effect of different diagnostic criteria on the prevalence of dementia.N Engl J Med 1997; 337 (23): 1667\u20131674.","journal-title":"N Engl J Med"},{"issue":"2","key":"BF02988444_CR41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/archneur.57.2.191","volume":"57","author":"HC Chui","year":"2000","unstructured":"Chui HC, Mack W, Jackson JE, Mungas D, Reed BR, Tinklenberg J, et al. Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.Arch Neurol 2000; 57 (2): 191\u2013196.","journal-title":"Arch Neurol"},{"key":"BF02988444_CR42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-510X(02)00282-4","volume":"203-204","author":"KA Jellinger","year":"2002","unstructured":"Jellinger KA. The pathology of ischemic-vascular dementia: An update.J Neurol Sci 2002; 203-204: 153\u2013157.","journal-title":"J Neurol Sci"},{"issue":"5","key":"BF02988444_CR43","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1212\/WNL.57.5.839","volume":"57","author":"M Ikeda","year":"2001","unstructured":"Ikeda M, Hokoishi K, Maki N, Nebu A, Tachibana N, Komori K, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study.Neurology 2001; 57 (5): 839\u2013844.","journal-title":"Neurology"},{"issue":"9","key":"BF02988444_CR44","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1001\/archneur.1992.00530330031011","volume":"49","author":"R Mielke","year":"1992","unstructured":"Mielke R, Herholz K, Grond M, Kessler J, Heiss WD. Severity of vascular dementia is related to volume of metabolically impaired tissue.Arch Neurol 1992; 49 (9): 909\u2013913.","journal-title":"Arch Neurol"},{"issue":"8","key":"BF02988444_CR45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archneur.1995.00540320049012","volume":"52","author":"DL Sultzer","year":"1995","unstructured":"Sultzer DL, Mahler ME, Cummings JL, Van Gorp WG, Hinkin CH, Brown C. Cortical abnormalities associated with subcortical lesions in vascular dementia. Clinical and position emission tomographic findings.Arch Neurol 1995; 52 (8): 773\u2013780.","journal-title":"Arch Neurol"},{"issue":"2","key":"BF02988444_CR46","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/archneur.1987.00520140035014","volume":"44","author":"KA Johnson","year":"1987","unstructured":"Johnson KA, Mueller ST, Walshe TM, English RJ, Holman BL. Cerebral perfusion imaging in Alzheimer\u2019s disease. Use of single photon emission computed tomography and iofetamine hydrochloride I-123.Arch Neurol 1987; 44 (2): 165\u2013168.","journal-title":"Arch Neurol"},{"issue":"4","key":"BF02988444_CR47","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1212\/WNL.42.4.765","volume":"42","author":"WJ Powers","year":"1992","unstructured":"Powers WJ, Perlmutter JS, Videen TO, Herscovitch P, Griffeth LK, Royal HD, et al. Blinded clinical evaluation of positron emission tomography for diagnosis of probable Alzheimer\u2019s disease.Neurology 1992; 42 (4): 765\u2013770.","journal-title":"Neurology"},{"key":"BF02988444_CR48","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1093\/brain\/104.4.753","volume":"104","author":"RS Frackowiak","year":"1981","unstructured":"Frackowiak RS, Pozzilli C, Legg NJ, Du Boulay GH, Marshall J, Lenzi GL, et al. Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.Brain 1981; 104 (Pt 4): 753\u2013778.","journal-title":"Brain"},{"issue":"1","key":"BF02988444_CR49","first-page":"1","volume":"35","author":"H Fukuyama","year":"1994","unstructured":"Fukuyama H, Ogawa M, Yamauchi H, Yamaguchi S, Kimura J, Yonekura Y, et al. Altered cerebral energy metabolism in Alzheimer\u2019s disease: a PET study.J Nucl Med 1994; 35 (1): 1\u20136.","journal-title":"J Nucl Med"},{"key":"BF02988444_CR50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1749-6632.2000.tb06375.x","volume":"903","author":"K Nagata","year":"2000","unstructured":"Nagata K, Maruya H, Yuya H, Terashi H, Mito Y, Kato H, et al. Can PET data differentiate Alzheimer\u2019s disease from vascular dementia?Ann NY Acad Sci 2000; 903: 252\u2013261.","journal-title":"Ann NY Acad Sci"},{"issue":"17","key":"BF02988444_CR51","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1001\/jama.286.17.2120","volume":"286","author":"DH Silverman","year":"2001","unstructured":"Silverman DH, Small GW, Chang CY, Lu CS, Kung de Aburto MA, Chen W, et al. Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcome.JAMA 2001; 286 (17): 2120\u20132127.","journal-title":"JAMA"},{"issue":"1","key":"BF02988444_CR52","first-page":"21","volume":"43","author":"K Herholz","year":"2002","unstructured":"Herholz K, Schopphoff H, Schmidt M, Mielke R, Eschner W, Scheidhauer K, et al. Direct comparison of spatially normalized PET and SPECT scans in Alzheimer disease.J Nucl Med 2002; 43 (1): 21\u201326.","journal-title":"J Nucl Med"},{"issue":"10","key":"BF02988444_CR53","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/BF00181059","volume":"21","author":"R Mielke","year":"1994","unstructured":"Mielke R, Pietrzyk U, Jacobs A, Fink GR, Ichimiya A, Kessler J, et al. HMPAO SPET and FDG PET in Alzheimer\u2019s disease and vascular dementia: comparison of perfusion and metabolic pattern.Eur J Nucl Med 1994; 21 (10): 1052\u20131060.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"BF02988444_CR54","first-page":"210","volume":"35","author":"C Messa","year":"1994","unstructured":"Messa C, Perani D, Lucignani G, Zenorini A, Zito F, Rizzo G, et al. High-resolution technetium-99m-HMPAO SPECT in patients with probable Alzheimer\u2019s disease: comparison with fluorine-18-FDG PET.J Nucl Med 1994; 35 (2): 210\u2013216.","journal-title":"J Nucl Med"},{"issue":"4","key":"BF02988444_CR55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S1536-1632(02)00016-1","volume":"4","author":"DHS Silverman","year":"2002","unstructured":"Silverman DHS, Cummings JL, Small GW, Gambhir SS, Chen W, Czernin J, et al. Added Clinical Benefit of Incorporating 2-Deoxy-2-[18F]Fluoro-d-Glucose with Positron Emission Tomography into the Clinical Evaluation of Patients with Cognitive Impairment.Molecular Imaging & Biology 2002; 4 (4): 283\u2013293.","journal-title":"Molecular Imaging & Biology"},{"issue":"3","key":"BF02988444_CR56","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1176\/appi.ajp.159.3.474","volume":"159","author":"N Okamura","year":"2002","unstructured":"Okamura N, Arai H, Maruyama M, Higuchi M, Matsui T, Tanji H, et al. Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer\u2019s Disease.Am J Psychiatry 2002; 159 (3): 474\u2013476.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"BF02988444_CR57","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2377-2-9","volume":"2","author":"C Huang","year":"2002","unstructured":"Huang C, Wahlund LO, Svensson L, Winblad B, Julin P. Cingulate cortex hypoperfusion predicts Alzheimer\u2019s disease in mild cognitive impairment.BMC Neurol 2002; 2 (1): 9.","journal-title":"BMC Neurol"},{"issue":"3","key":"BF02988444_CR58","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.1133","volume":"50","author":"S Minoshima","year":"2001","unstructured":"Minoshima S, Foster NL, Sima AA, Frey KA, Albin RL, Kuhl DE. Alzheimer\u2019s disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.Ann Neurol 2001; 50 (3): 358\u2013365.","journal-title":"Ann Neurol"},{"issue":"1","key":"BF02988444_CR59","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1212\/WNL.51.1.125","volume":"51","author":"K Ishii","year":"1998","unstructured":"Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer\u2019s disease.Neurology 1998; 51 (1): 125\u2013130.","journal-title":"Neurology"},{"issue":"5","key":"BF02988444_CR60","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. The metabolic topography of parkinsonism.J Cereb Blood Flow Metab 1994; 14 (5): 783\u2013801.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"12 Suppl 6","key":"BF02988444_CR61","first-page":"6","volume":"43","author":"DJ Brooks","year":"1993","unstructured":"Brooks DJ. PET studies on the early and differential diagnosis of Parkinson\u2019s disease.Neurology 1993; 43 (12 Suppl 6): S6\u201316.","journal-title":"Neurology"},{"issue":"2","key":"BF02988444_CR62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0022-510X(90)90236-G","volume":"95","author":"RH Perry","year":"1990","unstructured":"Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.J Neurol Sci 1990; 95 (2): 119\u2013139.","journal-title":"J Neurol Sci"},{"issue":"9","key":"BF02988444_CR63","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.53.9.1974","volume":"53","author":"J Verghese","year":"1999","unstructured":"Verghese J, Crystal HA, Dickson DW, Lipton RB. Validity of clinical criteria for the diagnosis of dementia with Lewy bodies.Neurology 1999; 53 (9): 1974\u20131982.","journal-title":"Neurology"},{"issue":"1\u20132","key":"BF02988444_CR64","first-page":"185","volume":"59","author":"KA Jellinger","year":"2000","unstructured":"Jellinger KA. Morphological substrates of mental dysfunction in Lewy body disease: an update.J Neural Transm Suppl 2000; 59 (1\u20132): 185\u2013212.","journal-title":"J Neural Transm Suppl"},{"key":"BF02988444_CR65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1001\/archneur.1997.00550140025008","volume":"54","author":"VA Holthoff-Detto","year":"1997","unstructured":"Holthoff-Detto VA, Kessler J, Herholz K, B\u00f6nner H, Pietrzyk U, W\u00fcrker M, et al. Functional effects of striatal dysfunction in Parkinson disease.Arch Neurol 1997; 54: 145\u2013150.","journal-title":"Arch Neurol"},{"issue":"Pt 6","key":"BF02988444_CR66","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1093\/brain\/awf134","volume":"125","author":"K Ito","year":"2002","unstructured":"Ito K, Nagano-Saito A, Kato T, Arahata Y, Nakamura A, Kawasumi Y, et al. Striatal and extrastriatal dysfunction in Parkinson\u2019s disease with dementia: a 6-[(18)F]fluolo-l-dopa PET study.Brain 2002; 125 (Pt 6): 1358\u20131365.","journal-title":"Brain"},{"issue":"10","key":"BF02988444_CR67","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/WNL.55.10.1575","volume":"55","author":"XS Hu","year":"2000","unstructured":"Hu XS, Okamura N, Arai H, Higuchi M, Matsui T, Tashiro M, et al.18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with lewy bodies.Neurology 2000; 55 (10): 1575\u20131577.","journal-title":"Neurology"},{"issue":"6","key":"BF02988444_CR68","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1136\/jnnp.67.6.737","volume":"67","author":"JO Rinne","year":"1999","unstructured":"Rinne JO, Ruottinen H, Bergman J, Haaparanta M, Sonninen P, Solin O. Usefulness of a dopamine transporter PET ligand[(18)F]beta-CFT in assessing disability in Parkinson\u2019s disease.J Neurol Neurosurg Psychiatry 1999; 67 (6): 737\u2013741.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"BF02988444_CR69","first-page":"2252","volume":"36","author":"TM Borght Vander","year":"1995","unstructured":"Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, et al.In vivo imaging of the brain vesicular monoamine transporter.J Nucl Med 1995; 36 (12): 2252\u20132260.","journal-title":"J Nucl Med"},{"issue":"4558","key":"BF02988444_CR70","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","volume":"217","author":"RT Bartus","year":"1982","unstructured":"Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction.Science 1982; 217 (4558): 408\u2013414.","journal-title":"Science"},{"issue":"7","key":"BF02988444_CR71","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00001756-199403000-00002","volume":"5","author":"EK Peny","year":"1994","unstructured":"Peny EK, Haroutunian V, Davis KL, Levy R, Lantos P, Eagger S, et al. Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer\u2019s disease.Neuroreport 1994; 5 (7): 747\u2013749.","journal-title":"Neuroreport"},{"key":"BF02988444_CR72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0022-510X(83)90045-X","volume":"59","author":"JM Candy","year":"1983","unstructured":"Candy JM, Perry RH, Perry EK, Irving D, Blessed G, Fairbairn AF, et al. Pathological changes in the nucleus basalis of Meynert in Alzheimer\u2019s and Parkinson\u2019s disease.J Neurol Sci 1983; 59: 277\u2013289.","journal-title":"J Neurol Sci"},{"issue":"3\u20134","key":"BF02988444_CR73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/BF00688058","volume":"71","author":"DM Mann","year":"1986","unstructured":"Mann DM, Yates PO, Marcyniuk B. The nucleus basalis of Meynert in multi-infarct (vascular) dementia.Acta Neuropathol (Berl) 1986; 71 (3\u20134): 332\u2013337.","journal-title":"Acta Neuropathol (Berl)"},{"issue":"8","key":"BF02988444_CR74","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0969-8051(98)00045-6","volume":"25","author":"SE Snyder","year":"1998","unstructured":"Snyder SE, Tluczek L, Jewett DM, Nguyen TB, Kuhl DE, Kilbourn MR. Synthesis of 1-[11C]methylpiperidin-4-yl propionate ([11C]PMP) forin vivo measurements of acetyl-cholinesterase activity.Nucl Med Biol 1998; 25 (8): 751\u2013754.","journal-title":"Nucl Med Biol"},{"issue":"2","key":"BF02988444_CR75","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/0006-8993(94)91507-5","volume":"667","author":"H Namba","year":"1994","unstructured":"Namba H, Irie T Fukushi K, Iyo M.In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog.Brain Research 1994; 667 (2): 278\u2013282.","journal-title":"Brain Research"},{"key":"BF02988444_CR76","first-page":"41","volume-title":"Brain Imaging Using PET","author":"G Z\u00fcndorf","year":"2002","unstructured":"Z\u00fcndorf G, Herholz K, Lercher M, Wienhard K, Bauer B, Weisenbach S, Heiss W-D. PET functional parametric images of acetylcholine esterase activity without blood sampling. Senda M, Kimura Y, Herscovitch P, eds.Brain Imaging Using PET. San Diego, Ca.; Academic Press, 2002: 41\u201346."},{"key":"BF02988444_CR77","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s002590100492","volume":"28","author":"K Herholz","year":"2001","unstructured":"Herholz K, Lercher M, Wienhard K, Bauer B, Lenz O, Heiss W-D. PET measurement of cerebral acetylcholine esterase activity without blood sampling.Eur J Nucl Med 2001; 28: 472\u2013477.","journal-title":"Eur J Nucl Med"},{"issue":"2","key":"BF02988444_CR78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1531-8249(200008)48:2<194::AID-ANA9>3.0.CO;2-X","volume":"48","author":"H Shinotoh","year":"2000","unstructured":"Shinotoh H, Namba H, Fukushi K, Nagatsuka S, Tanaka N, Aotsuka A, et al. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer\u2019s disease: a positron emission tomography study.Ann Neurol 2000; 48 (2): 194\u2013200.","journal-title":"Ann Neurol"},{"key":"BF02988444_CR79","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s007020070009","volume":"12","author":"K Herholz","year":"2000","unstructured":"Herholz K, Bauer B, Wienhard K, Kracht L, Mielke R, Lenz O, et al.In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.J Neural Transm 2000; 12: 1457\u20131468.","journal-title":"J Neural Transm"},{"issue":"2","key":"BF02988444_CR80","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00002093-199307020-00002","volume":"7","author":"EK Perry","year":"1993","unstructured":"Perry EK, Irving D, Kerwin JM, McKeith IG, Thompson P, Collerton D, et al. Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson\u2019s and distinction from Alzheimer disease.Alzheimer Disease & Associated Disorders 1993; 7 (2): 69\u201379.","journal-title":"Alzheimer Disease & Associated Disorders"},{"issue":"3","key":"BF02988444_CR81","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-3223(00)01112-4","volume":"49","author":"ND Volkow","year":"2001","unstructured":"Volkow ND, Ding YS, Fowler JS, Gatley SJ. Imaging brain cholinergic activity with positron emission tomography: its role in the evaluation of cholinergic treatments in Alzheimer\u2019s dementia.Biol Psychiatry 2001; 49 (3): 211\u2013220.","journal-title":"Biol Psychiatry"},{"key":"BF02988444_CR82","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1034\/j.1600-0404.2000.00304.x","volume":"176","author":"W Sihver","year":"2000","unstructured":"Sihver W, Langstrom B, Nordberg A. Ligands forin vivo imaging of nicotinic receptor subtypes in Alzheimer brain.Acta Neurol Scand Suppl 2000; 176: 27\u201333.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"9","key":"BF02988444_CR83","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/00004647-200209000-00001","volume":"22","author":"BJ Bacskai","year":"2002","unstructured":"Bacskai BJ, Klunk WE, Mathis CA, Hyman BT. Imaging Amyloid-beta DepositsIn Vivo.J Cereb Blood Flow Metab 2002; 22 (9): 1035\u20131041.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"1","key":"BF02988444_CR84","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/00019442-200201000-00004","volume":"10","author":"K Shoghi-Jadid","year":"2002","unstructured":"Shoghi-Jadid K, Small GW, Agdeppa ED, Kepe V, Ercoli LM, Siddarth P, et al. Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease.Am J Geriatr Psychiatry 2002; 10 (1): 24\u201335.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"BF02988444_CR85","first-page":"297","volume":"3","author":"SI Rapoport","year":"1991","unstructured":"Rapoport SI. Positron emission tomography in Alzheimer\u2019s disease in relation to disease pathogenesis\u2014a critical review.Cerebrovascular & Brain Metabolism Reviews 1991; 3 (4): 297\u2013335.","journal-title":"Cerebrovascular & Brain Metabolism Reviews"},{"issue":"3","key":"BF02988444_CR86","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1159\/000051257","volume":"12","author":"T Imamura","year":"2001","unstructured":"Imamura T, Ishii K, Hirono N, Hashimoto M, Tanimukai S, Kazui H, et al. Occipital glucose metabolism in dementia with lewy bodies with and without parkinsonism: a study using positron emission tomography.Dement Geriatr Cogn Disord 2001; 12 (3): 194\u2013197.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"2","key":"BF02988444_CR87","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1006\/exnr.2000.7342","volume":"162","author":"M Higuchi","year":"2000","unstructured":"Higuchi M, Tashiro M, Arai H, Okamura N, Hara S, Higuchi S, et al. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.Exp Neurol 2000; 162 (2): 247\u2013256.","journal-title":"Exp Neurol"},{"issue":"Suppl 1","key":"BF02988444_CR88","first-page":"14","volume":"249","author":"E Salmon","year":"2002","unstructured":"Salmon E, Delbeuck X, Garraux G, Collette F, Herholz K, Kalbe E, et al. A predominant ventromedial frontopolar metabolic impairment demonstrated in frontotemporal dementia.J Neurol 2002; 249 (Suppl 1): 14.","journal-title":"J Neurol"},{"key":"BF02988444_CR89","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s004060170031","volume":"251","author":"M Jauss","year":"2001","unstructured":"Jauss M, Herholz K, Kracht L, Pantel J, Hartmann T, Jensen M, et al. Frontotemporal dementia: Clinical, neuroimaging, and molecular biological findings in 6 patients.European Archives of Psychiatry & Clinical Neuroscience 2001; 251: 225\u2013231.","journal-title":"European Archives of Psychiatry & Clinical Neuroscience"},{"issue":"11","key":"BF02988444_CR90","first-page":"1875","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, et al. Cerebral glucose metabolism in patients with frontotemporal dementia.J Nucl Med 1998; 39 (11): 1875\u20131878.","journal-title":"J Nucl Med"},{"issue":"3\u20134","key":"BF02988444_CR91","first-page":"192","volume":"4","author":"RP Friedland","year":"1993","unstructured":"Friedland RP, Koss E, Lemer A, Hedera P, Ellis W, Dronkers N, et al. Functional imaging, the frontal lobes, and dementia.Dementia 1993; 4 (3\u20134): 192\u2013203.","journal-title":"Dementia"},{"key":"BF02988444_CR92","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00702-002-0696-5","volume":"10","author":"R Hilker","year":"2002","unstructured":"Hilker R, Voges J, Thiel A, Ghaemi M, Herholz K, Sturm V, et al. Deep brain stimulation of the subthalamic nucleus versus levodopa challenge in Parkinson\u2019s disease: measuring the on- and off-conditions with FDG-PET.J Neural Transmission 2002; 10: 1257\u20131264.","journal-title":"J Neural Transmission"},{"issue":"6","key":"BF02988444_CR93","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/mds.1212","volume":"16","author":"G Berding","year":"2001","unstructured":"Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, et al. Resting regional cerebral glucose metabolism in advanced Parkinson\u2019s disease studied in the off and on conditions with [(18)F]FDG-PET.Mov Disord 2001; 16 (6): 1014\u20131022.","journal-title":"Mov Disord"},{"issue":"Pt 8","key":"BF02988444_CR94","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/brain\/124.8.1601","volume":"124","author":"M Fukuda","year":"2001","unstructured":"Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, et al. Networks mediating the clinical effects of pallidal brain stimulation for Parkinson\u2019s disease: a PET study of resting-state glucose metabolism.Brain 2001; 124 (Pt 8): 1601\u20131609.","journal-title":"Brain"},{"issue":"4","key":"BF02988444_CR95","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ana.1232","volume":"50","author":"PC Su","year":"2001","unstructured":"Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. Metabolic changes following subthalamotomy for advanced Parkinson\u2019s disease.Ann Neurol 2001; 50 (4): 514\u2013520.","journal-title":"Ann Neurol"},{"issue":"3","key":"BF02988444_CR96","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1212\/WNL.52.3.541","volume":"52","author":"NI Bohnen","year":"1999","unstructured":"Bohnen NI, Minoshima S, Giordani B, Frey KA, Kuhl DE. Motor correlates of occipital glucose hypometabolism in Parkinson\u2019s disease without dementia.Neurology 1999; 52 (3): 541\u2013546.","journal-title":"Neurology"},{"issue":"3","key":"BF02988444_CR97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/mds.870050304","volume":"5","author":"D Eidelberg","year":"1990","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Sidtis JJ, Ginos JZ, Strother SC, et al. The metabolic anatomy of Parkinson\u2019s disease: complementary [18F] fluorodeoxyglucose and [18F]fluorodopa positron emission tomographic studies.Movement Disorders 1990; 5 (3): 203\u2013213.","journal-title":"Movement Disorders"},{"issue":"5","key":"BF02988444_CR98","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/ana.410330517","volume":"33","author":"D Eidelberg","year":"1993","unstructured":"Eidelberg D, Takikawa S, Moeller JR, Dhawan V, Redington K, Chaly T, et al. Striatal hypometabolism distinguishes striatonigral degeneration from Parkinson\u2019s disease.Ann Neurol 1993; 33 (5): 518\u2013527.","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"BF02988444_CR99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-510X(02)00151-X","volume":"200","author":"T Taniwaki","year":"2002","unstructured":"Taniwaki T, Nakagawa M, Yamada T, Yoshida T, Ohyagi Y, Sasaki M, et al. Cerebral metabolic changes in early multiple system atrophy: a PET study.J Neurol Sci 2002; 200 (1\u20132): 79\u201384.","journal-title":"J Neurol Sci"},{"issue":"5","key":"BF02988444_CR100","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/jnnp.73.5.517","volume":"73","author":"M Ghaemi","year":"2002","unstructured":"Ghaemi M, Hilker R, Rudolf J, Sobesky J, Heiss WD. Differentiating multiple system atrophy from Parkinson\u2019s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging.J Neurol Neurosurg Psychiatry 2002; 73 (5): 517\u2013523.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"BF02988444_CR101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF01826055","volume":"1","author":"MJ Fulham","year":"1991","unstructured":"Fulham MJ, Dubinsky RM, Pohnsky RJ, Brooks RA, Brown RT, Curras MT, et al. Computed tomography, magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in multiple system atrophy and pule autonomic failure.Clinical Autonomic Research 1991; 1 (1): 27\u201336.","journal-title":"Clinical Autonomic Research"},{"issue":"2","key":"BF02988444_CR102","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.410360208","volume":"36","author":"S Gilman","year":"1994","unstructured":"Gilman S, Koeppe RA, Junck L, Kluin KJ, Lohman M, St Laurent RT. Patterns of cerebral glucose metabolism detected with positron emission tomography differ in multiple system atrophy and olivopontocerebellar atrophy.Ann Neurol 1994; 36 (2): 166\u2013175.","journal-title":"Ann Neurol"},{"issue":"2","key":"BF02988444_CR103","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/archneur.1995.00540260085021","volume":"52","author":"D Perani","year":"1995","unstructured":"Perani D, Bressi S, Testa D, Grassi F, Cortelli P, Gentrini S, et al. Clinical\/metabolic correlations in multiple system atrophy. A fludeoxyglucose F 18 positron emission tomographic study.Arch Neurol 1995; 52 (2): 179\u2013185.","journal-title":"Arch Neurol"},{"issue":"11","key":"BF02988444_CR104","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1001\/archneur.58.11.1846","volume":"58","author":"P Piccini","year":"2001","unstructured":"Piccini P, de Yebenez J, Lees AJ, Ceravolo R, Turjanski N, Pramstaller P, et al. Familial progressive supranuclear palsy: detection of subclinical cases using18F-dopa and18fluorodeoxyglucose positron emission tomography.Arch Neurol 2001; 58 (11): 1846\u20131851.","journal-title":"Arch Neurol"},{"issue":"7","key":"BF02988444_CR105","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archneur.1990.00530070035009","volume":"47","author":"J Blin","year":"1990","unstructured":"Blin J, Baron JC, Dubois B, Pillon B, Cambon H, Cambier J, et al. Positron emission tomography study in progressive supranuclear palsy. Brain hypometabolic pattern and clinicometabolic correlations.Arch Neurol 1990; 47 (7): 747\u2013752.","journal-title":"Arch Neurol"},{"issue":"2","key":"BF02988444_CR106","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/0022-510X(96)00057-3","volume":"139","author":"H Nagasawa","year":"1996","unstructured":"Nagasawa H, Tanji H, Nomura H, Saito H, Itoyama Y, Kimura I, et al. PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.J Neurol Sci 1996; 139 (2): 210\u2013217.","journal-title":"J Neurol Sci"},{"issue":"4","key":"BF02988444_CR107","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/mds.870070409","volume":"7","author":"J Blin","year":"1992","unstructured":"Blin J, Vidailhet MJ, Pillon B, Dubois B, Feve JR, Agid Y. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET.Movement Disorders 1992; 7 (4): 348\u2013354.","journal-title":"Movement Disorders"},{"issue":"10","key":"BF02988444_CR108","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/jnnp.54.10.856","volume":"54","author":"D Eidelberg","year":"1991","unstructured":"Eidelberg D, Dhawan V, Moeller JR, Sidtis JJ, Ginos JZ, Strother SC, et al. The metabolic landscape of corticobasal ganglionic degeneration: regional asymmetries studied with positron emission tomography.J Neurol Neurosurg Psychiatry 1991; 54 (10): 856\u2013862.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"6","key":"BF02988444_CR109","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ana.410280605","volume":"28","author":"S Gilman","year":"1990","unstructured":"Gilman S, Junck L, Markel DS, Koeppe RA, Kluin KJ. Cerebral glucose hypermetabolism in Friedreich\u2019s ataxia detected with positron emission tomography.Ann Neurol 1990; 28 (6): 750\u2013757.","journal-title":"Ann Neurol"},{"issue":"4","key":"BF02988444_CR110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0303-8467(00)00113-X","volume":"102","author":"J Rudolf","year":"2000","unstructured":"Rudolf J, Grond M, Hilker R, Ghaemi M, Jacobs A, Heiss W. Relative sparing of the parietal cortex in cerebellar ataxia documented by positron emission tomography.Clinl Neurol Neurosurg 2000; 102 (4): 210\u2013214.","journal-title":"Clinl Neurol Neurosurg"},{"issue":"1","key":"BF02988444_CR111","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.870010110","volume":"1","author":"KL Leenders","year":"1986","unstructured":"Leenders KL, Frackowiak RS, Quinn N, Marsden CD. Brain energy metabolism and dopaminergic function in Huntington\u2019s disease measuredin vivo using positron emission tomography.Movement Disorders 1986; 1 (1): 69\u201377.","journal-title":"Movement Disorders"},{"issue":"3","key":"BF02988444_CR112","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"AB Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, et al. PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline.Ann Neurol 1986; 20 (3): 296\u2013303.","journal-title":"Ann Neurol"},{"issue":"7","key":"BF02988444_CR113","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","volume":"36","author":"MR Hayden","year":"1986","unstructured":"Hayden MR, Martin WR, Stoessl AJ, Clark C, Hollenberg S, Adam MJ, et al. Positron emission tomography in the early diagnosis of Huntington\u2019s disease.Neurology 1986; 36 (7): 888\u2013894.","journal-title":"Neurology"},{"issue":"4","key":"BF02988444_CR114","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1055\/s-2008-1041346","volume":"9","author":"JC Mazziotta","year":"1989","unstructured":"Mazziotta JC. Huntington\u2019s disease: studies with structural imaging techniques and positron emission tomography.Semin Neurol 1989; 9 (4): 360\u2013369.","journal-title":"Semin Neurol"},{"issue":"2","key":"BF02988444_CR115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/archpsyc.1992.01820020068009","volume":"49","author":"LR Baxter","year":"1992","unstructured":"Baxter LR Jr, Mazziotta JC, Pahl JJ, Grafton ST, St George-Hyslop P, Haines JL, et al. Psychiatric, genetic, and positron emission tomographic evaluation of persons at risk for Huntington\u2019s disease.Archives of General Psychiatry 1992; 49 (2): 148\u2013154.","journal-title":"Archives of General Psychiatry"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988444.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02988444\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988444","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,21]],"date-time":"2023-05-21T03:05:47Z","timestamp":1684638347000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02988444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,4]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["BF02988444"],"URL":"https:\/\/doi.org\/10.1007\/bf02988444","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,4]]}}}